ロード中...
CNS-targeting pharmacological interventions for the metabolic syndrome
The metabolic syndrome (MetS) encompasses medical conditions such as obesity, hyperglycemia, high blood pressure, and dyslipidemia that are major drivers for the ever-increasing prevalence of type 2 diabetes, cardiovascular diseases, and certain types of cancer. At the core of clinical strategies ag...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763237/ https://ncbi.nlm.nih.gov/pubmed/31380808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI129195 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|